tradingkey.logo
搜索

Tactile Systems Technology Inc

TCMD
添加自选
31.350USD
+0.700+2.28%
收盘 07/02, 13:00美东报价延迟15分钟
707.14M总市值
35.56市盈率 TTM

Tactile Systems Technology Inc

31.350
+0.700+2.28%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.28%

5天

+11.96%

1月

+28.43%

6月

+14.42%

今年开始到现在

+8.10%

1年

+209.48%

关键数据
30.810今开
31.420最高
382.95K成交量
35.56市盈率 TTM
20.36市盈率动
--股息TTM
1.71%换手率
30.650昨收
29.840最低
8.99M成交额
41.48市盈率静
3.21市净率
0.00%股息率 TTM
7.35%ROA
37.77052周最高
1.71量比
16.96M净利润
22.44M总股本
0.8817每股收益TTM
0.84Beta
9.59%ROE
9.41552周最低
5.15%振幅
75.75%毛利率
707.14M总市值
9.86回报/风险
2.61%风险率

操作建议

Tactile Systems Technology Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名39/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价39.50。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Tactile Systems Technology Inc评分

相关信息

行业排名
39 / 204
全市场排名
113 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Tactile Systems Technology Inc亮点

亮点风险
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
业绩高增长
公司营业收入稳步增长,连续3年增长20.08%
估值高估
公司最新PE估值35.56,处于3年历史高位
机构减仓
最新机构持股24.21M股,环比减少9.57%
ETHSX持仓
明星投资者ETHSX持仓,最新持仓市值158.76K

分析师目标

根据 5 位分析师
买入
评级
20.500
目标均价
+55.07%
涨幅空间

Tactile Systems Technology Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Tactile Systems Technology Inc简介

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
公司代码TCMD
公司Tactile Systems Technology Inc
CEODodd (Sheri L)
网址https://www.tactilemedical.com/

常见问题

Tactile Systems Technology Inc(TCMD)的当前股价是多少?

Tactile Systems Technology Inc(TCMD)的当前股价是 31.35。

Tactile Systems Technology Inc的股票代码是什么?

Tactile Systems Technology Inc的股票代码是TCMD。

Tactile Systems Technology Inc股票的52周最高点是多少?

Tactile Systems Technology Inc股票的52周最高点是37.77。

Tactile Systems Technology Inc股票的52周最低点是多少?

Tactile Systems Technology Inc股票的52周最低点是9.41。

Tactile Systems Technology Inc的市值是多少?

Tactile Systems Technology Inc的市值是703.46M。

现在Tactile Systems Technology Inc(TCMD)的股票是买入、持有还是卖出?

根据分析师评级,Tactile Systems Technology Inc(TCMD)的总体评级为买入,目标价格为39.50。

Tactile Systems Technology Inc(TCMD)股票的每股收益(EPS TTM)是多少

Tactile Systems Technology Inc(TCMD)股票的每股收益(EPS TTM)是0.83。